Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 211 entries
Sorted by: Best Match Show Resources per page
Azilsartan as a Potent Antihypertensive Drug with Possible Pleiotropic Cardiometabolic Effects: A Review Study.

Frontiers in pharmacology

Georgiopoulos G, Katsi V, Oikonomou D, Vamvakou G, Koutli E, Laina A, Tsioufis C, Nihoyannopoulos P, Tousoulis D.
PMID: 27536242
Front Pharmacol. 2016 Aug 03;7:235. doi: 10.3389/fphar.2016.00235. eCollection 2016.

BACKGROUND: Hypertension related cardiovascular (CV) complications could be amplified by the presence of metabolic co-morbidities. Azilsartan medoxomil (AZL-M) is the eighth approved member of angiotensin II receptor blockers (ARBs), a drug class of high priority in the management of...

Cite
Georgiopoulos G, Katsi V, Oikonomou D, et al. Azilsartan as a Potent Antihypertensive Drug with Possible Pleiotropic Cardiometabolic Effects: A Review Study. Front Pharmacol. 2016;7:235doi: 10.3389/fphar.2016.00235.
Georgiopoulos, G., Katsi, V., Oikonomou, D., Vamvakou, G., Koutli, E., Laina, A., Tsioufis, C., Nihoyannopoulos, P., & Tousoulis, D. (2016). Azilsartan as a Potent Antihypertensive Drug with Possible Pleiotropic Cardiometabolic Effects: A Review Study. Frontiers in pharmacology, 7235. https://doi.org/10.3389/fphar.2016.00235
Georgiopoulos, Georgios, et al. "Azilsartan as a Potent Antihypertensive Drug with Possible Pleiotropic Cardiometabolic Effects: A Review Study." Frontiers in pharmacology vol. 7 (2016): 235. doi: https://doi.org/10.3389/fphar.2016.00235
Georgiopoulos G, Katsi V, Oikonomou D, Vamvakou G, Koutli E, Laina A, Tsioufis C, Nihoyannopoulos P, Tousoulis D. Azilsartan as a Potent Antihypertensive Drug with Possible Pleiotropic Cardiometabolic Effects: A Review Study. Front Pharmacol. 2016 Aug 03;7:235. doi: 10.3389/fphar.2016.00235. eCollection 2016. PMID: 27536242; PMCID: PMC4971108.
Copy Download .nbib Format: NLM
Economic evaluation of trimetazidine in the management of chronic stable angina in Greece.

BMC health services research

Kourlaba G, Gourzoulidis G, Andrikopoulos G, Tsioufis K, Beletsi A, Maniadakis N.
PMID: 27678370
BMC Health Serv Res. 2016 Sep 27;16(1):520. doi: 10.1186/s12913-016-1779-6.

BACKGROUND: To evaluate the cost-effectiveness of trimetazidine (TMZ) as add-on therapy to standard-of-care (SoC) compared to SoC alone in patients with chronic stable angina who did not respond adequately to first line therapy with b-blockers, nitrates or calcium channel...

Cite
Kourlaba G, Gourzoulidis G, Andrikopoulos G, et al. Economic evaluation of trimetazidine in the management of chronic stable angina in Greece. BMC Health Serv Res. 2016;16(1):520doi: 10.1186/s12913-016-1779-6.
Kourlaba, G., Gourzoulidis, G., Andrikopoulos, G., Tsioufis, K., Beletsi, A., & Maniadakis, N. (2016). Economic evaluation of trimetazidine in the management of chronic stable angina in Greece. BMC health services research, 16(1), 520. https://doi.org/10.1186/s12913-016-1779-6
Kourlaba, Georgia, et al. "Economic evaluation of trimetazidine in the management of chronic stable angina in Greece." BMC health services research vol. 16,1 (2016): 520. doi: https://doi.org/10.1186/s12913-016-1779-6
Kourlaba G, Gourzoulidis G, Andrikopoulos G, Tsioufis K, Beletsi A, Maniadakis N. Economic evaluation of trimetazidine in the management of chronic stable angina in Greece. BMC Health Serv Res. 2016 Sep 27;16(1):520. doi: 10.1186/s12913-016-1779-6. PMID: 27678370; PMCID: PMC5039874.
Copy Download .nbib Format: NLM
Statins and inflammation in cardiovascular disease.

Current pharmaceutical design

Vogiatzi G, Oikonomou E, Siasos G, Tsalamandris S, Briasoulis A, Androulakis E, Latsios G, Papaioannou S, Tsioufis K, Tousoulis D.
PMID: 28990524
Curr Pharm Des. 2017 Oct 09; doi: 10.2174/1381612823666171009141201. Epub 2017 Oct 09.

BACKGROUND: Chronic inflammation and immune system activation underlie a variety of seemingly unrelated cardiac conditions including not only atherosclerosis and the subsequent coronary artery disease but also peripheral artery disease, hypertension with target organ damage and heart failure. The...

Cite
Vogiatzi G, Oikonomou E, Siasos G, et al. Statins and inflammation in cardiovascular disease. Curr Pharm Des. 2017;doi: 10.2174/1381612823666171009141201.
Vogiatzi, G., Oikonomou, E., Siasos, G., Tsalamandris, S., Briasoulis, A., Androulakis, E., Latsios, G., Papaioannou, S., Tsioufis, K., & Tousoulis, D. (2017). Statins and inflammation in cardiovascular disease. Current pharmaceutical design, . https://doi.org/10.2174/1381612823666171009141201
Vogiatzi, Georgia, et al. "Statins and inflammation in cardiovascular disease." Current pharmaceutical design vol. (2017). doi: https://doi.org/10.2174/1381612823666171009141201
Vogiatzi G, Oikonomou E, Siasos G, Tsalamandris S, Briasoulis A, Androulakis E, Latsios G, Papaioannou S, Tsioufis K, Tousoulis D. Statins and inflammation in cardiovascular disease. Curr Pharm Des. 2017 Oct 09; doi: 10.2174/1381612823666171009141201. Epub 2017 Oct 09. PMID: 28990524.
Copy Download .nbib Format: NLM
E-health in 2017: Rebooting cardiovascular care.

Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese

Tsioufis C.
PMID: 28522330
Hellenic J Cardiol. 2017 Mar - Apr;58(2):169-170. doi: 10.1016/j.hjc.2017.04.005. Epub 2017 May 15.

No abstract available.

Cite
Tsioufis C. E-health in 2017: Rebooting cardiovascular care. Hellenic J Cardiol. 2017;58(2):169-170doi: 10.1016/j.hjc.2017.04.005.
Tsioufis, C. (2017). E-health in 2017: Rebooting cardiovascular care. Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese, 58(2), 169-170. https://doi.org/10.1016/j.hjc.2017.04.005
Tsioufis, Costas. "E-health in 2017: Rebooting cardiovascular care." Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese vol. 58,2 (2017): 169-170. doi: https://doi.org/10.1016/j.hjc.2017.04.005
Tsioufis C. E-health in 2017: Rebooting cardiovascular care. Hellenic J Cardiol. 2017 Mar - Apr;58(2):169-170. doi: 10.1016/j.hjc.2017.04.005. Epub 2017 May 15. PMID: 28522330.
Copy Download .nbib Format: NLM
In situ growth of capping-free magnetic iron oxide nanoparticles on liquid-phase exfoliated graphene.

Nanoscale

Tsoufis T, Syrgiannis Z, Akhtar N, Prato M, Katsaros F, Sideratou Z, Kouloumpis A, Gournis D, Rudolf P.
PMID: 25920624
Nanoscale. 2015 May 21;7(19):8995-9003. doi: 10.1039/c5nr00765h.

We report a facile approach for the in situ synthesis of very small iron oxide nanoparticles on the surface of high-quality graphene sheets. Our synthetic strategy involved the direct, liquid-phase exfoliation of highly crystalline graphite (avoiding any oxidation treatment)...

Cite
Tsoufis T, Syrgiannis Z, Akhtar N, et al. In situ growth of capping-free magnetic iron oxide nanoparticles on liquid-phase exfoliated graphene. Nanoscale. 2015;7(19):8995-9003doi: 10.1039/c5nr00765h.
Tsoufis, T., Syrgiannis, Z., Akhtar, N., Prato, M., Katsaros, F., Sideratou, Z., Kouloumpis, A., Gournis, D., & Rudolf, P. (2015). In situ growth of capping-free magnetic iron oxide nanoparticles on liquid-phase exfoliated graphene. Nanoscale, 7(19), 8995-9003. https://doi.org/10.1039/c5nr00765h
Tsoufis, T, et al. "In situ growth of capping-free magnetic iron oxide nanoparticles on liquid-phase exfoliated graphene." Nanoscale vol. 7,19 (2015): 8995-9003. doi: https://doi.org/10.1039/c5nr00765h
Tsoufis T, Syrgiannis Z, Akhtar N, Prato M, Katsaros F, Sideratou Z, Kouloumpis A, Gournis D, Rudolf P. In situ growth of capping-free magnetic iron oxide nanoparticles on liquid-phase exfoliated graphene. Nanoscale. 2015 May 21;7(19):8995-9003. doi: 10.1039/c5nr00765h. PMID: 25920624.
Copy Download .nbib Format: NLM
Primary plasmacytoma of the cranial vault: a case report.

Cases journal

Zigouris A, Drosos D, Alexiou GA, Fotakopoulos G, Mihos E, Pahatouridis D, Tsiouris S, Fotopoulos AD, Voulgaris S.
PMID: 20062671
Cases J. 2009 Dec 07;2:9154. doi: 10.1186/1757-1626-2-9154.

We report one case of a 78-year-old woman who referred to our hospital because of a progressive right hemiparesis. On clinical examination a painless large soft mass in the left parietal region was observed. CT and MRI revealed an...

Cite
Zigouris A, Drosos D, Alexiou GA, et al. Primary plasmacytoma of the cranial vault: a case report. Cases J. 2009;2:9154doi: 10.1186/1757-1626-2-9154.
Zigouris, A., Drosos, D., Alexiou, G. A., Fotakopoulos, G., Mihos, E., Pahatouridis, D., Tsiouris, S., Fotopoulos, A. D., & Voulgaris, S. (2009). Primary plasmacytoma of the cranial vault: a case report. Cases journal, 29154. https://doi.org/10.1186/1757-1626-2-9154
Zigouris, Anrdeas, et al. "Primary plasmacytoma of the cranial vault: a case report." Cases journal vol. 2 (2009): 9154. doi: https://doi.org/10.1186/1757-1626-2-9154
Zigouris A, Drosos D, Alexiou GA, Fotakopoulos G, Mihos E, Pahatouridis D, Tsiouris S, Fotopoulos AD, Voulgaris S. Primary plasmacytoma of the cranial vault: a case report. Cases J. 2009 Dec 07;2:9154. doi: 10.1186/1757-1626-2-9154. PMID: 20062671; PMCID: PMC2803951.
Copy Download .nbib Format: NLM
Difficult-to-Treat or Resistant Hypertension: Etiology, Pathophysiology, and Innovative Therapies.

International journal of hypertension

Papademetriou V, Tsioufis K, Gradman A, Punzi H.
PMID: 21822477
Int J Hypertens. 2011;2011:438198. doi: 10.4061/2011/438198. Epub 2011 Jun 01.

Despite the many therapeutic options available today for the treatment of hypertension, a sizable number of patients still remain resistant to treatment. The prevalence of resistant hypertension in the general population under optimal conditions is about 3-5%. Although several...

Cite
Papademetriou V, Tsioufis K, Gradman A, et al. Difficult-to-Treat or Resistant Hypertension: Etiology, Pathophysiology, and Innovative Therapies. Int J Hypertens. 2011;2011:438198doi: 10.4061/2011/438198.
Papademetriou, V., Tsioufis, K., Gradman, A., & Punzi, H. (2011). Difficult-to-Treat or Resistant Hypertension: Etiology, Pathophysiology, and Innovative Therapies. International journal of hypertension, 2011438198. https://doi.org/10.4061/2011/438198
Papademetriou, Vasilios, et al. "Difficult-to-Treat or Resistant Hypertension: Etiology, Pathophysiology, and Innovative Therapies." International journal of hypertension vol. 2011 (2011): 438198. doi: https://doi.org/10.4061/2011/438198
Papademetriou V, Tsioufis K, Gradman A, Punzi H. Difficult-to-Treat or Resistant Hypertension: Etiology, Pathophysiology, and Innovative Therapies. Int J Hypertens. 2011;2011:438198. doi: 10.4061/2011/438198. Epub 2011 Jun 01. PMID: 21822477; PMCID: PMC3124360.
Copy Download .nbib Format: NLM
Tailor-made graphite oxide-DAB poly(propylene imine) dendrimer intercalated hybrids and their potential for efficient CO₂ adsorption.

Chemical communications (Cambridge, England)

Tsoufis T, Katsaros F, Sideratou Z, Romanos G, Ivashenko O, Rudolf P, Kooi BJ, Papageorgiou S, Karakassides MA.
PMID: 25093640
Chem Commun (Camb). 2014 Sep 28;50(75):10967-70. doi: 10.1039/c4cc03996c. Epub 2014 Aug 05.

We report the rational design and synthesis of DAB poly(propylene imine) dendrimer (DAB) intercalated graphite oxide (GO) hybrids with tailorable interlayer distances. The amine groups originating from the intercalated dendrimer molecules cross-link adjacent GO sheets and strongly favour CO2...

Cite
Tsoufis T, Katsaros F, Sideratou Z, et al. Tailor-made graphite oxide-DAB poly(propylene imine) dendrimer intercalated hybrids and their potential for efficient CO₂ adsorption. Chem Commun (Camb). 2014;50(75):10967-70doi: 10.1039/c4cc03996c.
Tsoufis, T., Katsaros, F., Sideratou, Z., Romanos, G., Ivashenko, O., Rudolf, P., Kooi, B. J., Papageorgiou, S., & Karakassides, M. A. (2014). Tailor-made graphite oxide-DAB poly(propylene imine) dendrimer intercalated hybrids and their potential for efficient CO₂ adsorption. Chemical communications (Cambridge, England), 50(75), 10967-70. https://doi.org/10.1039/c4cc03996c
Tsoufis, T, et al. "Tailor-made graphite oxide-DAB poly(propylene imine) dendrimer intercalated hybrids and their potential for efficient CO₂ adsorption." Chemical communications (Cambridge, England) vol. 50,75 (2014): 10967-70. doi: https://doi.org/10.1039/c4cc03996c
Tsoufis T, Katsaros F, Sideratou Z, Romanos G, Ivashenko O, Rudolf P, Kooi BJ, Papageorgiou S, Karakassides MA. Tailor-made graphite oxide-DAB poly(propylene imine) dendrimer intercalated hybrids and their potential for efficient CO₂ adsorption. Chem Commun (Camb). 2014 Sep 28;50(75):10967-70. doi: 10.1039/c4cc03996c. Epub 2014 Aug 05. PMID: 25093640.
Copy Download .nbib Format: NLM
Benefits from treatment and control of patients with resistant hypertension.

International journal of hypertension

Doumas M, Papademetriou V, Douma S, Faselis C, Tsioufis K, Gkaliagkousi E, Petidis K, Zamboulis C.
PMID: 21234402
Int J Hypertens. 2010 Dec 22;2011:318549. doi: 10.4061/2011/318549.

Resistant hypertension is commonly found in everyday clinical practice. However, the risks of resistant hypertension, as well as the benefits of treatment and control of blood pressure in patients with resistant hypertension remain vaguely clarified. Data from small clinical...

Cite
Doumas M, Papademetriou V, Douma S, et al. Benefits from treatment and control of patients with resistant hypertension. Int J Hypertens. 2010;2011:318549doi: 10.4061/2011/318549.
Doumas, M., Papademetriou, V., Douma, S., Faselis, C., Tsioufis, K., Gkaliagkousi, E., Petidis, K., & Zamboulis, C. (2010). Benefits from treatment and control of patients with resistant hypertension. International journal of hypertension, 2011318549. https://doi.org/10.4061/2011/318549
Doumas, Michael, et al. "Benefits from treatment and control of patients with resistant hypertension." International journal of hypertension vol. 2011 (2010): 318549. doi: https://doi.org/10.4061/2011/318549
Doumas M, Papademetriou V, Douma S, Faselis C, Tsioufis K, Gkaliagkousi E, Petidis K, Zamboulis C. Benefits from treatment and control of patients with resistant hypertension. Int J Hypertens. 2010 Dec 22;2011:318549. doi: 10.4061/2011/318549. PMID: 21234402; PMCID: PMC3014695.
Copy Download .nbib Format: NLM
Pathophysiology of resistant hypertension: the role of sympathetic nervous system.

International journal of hypertension

Tsioufis C, Kordalis A, Flessas D, Anastasopoulos I, Tsiachris D, Papademetriou V, Stefanadis C.
PMID: 21331155
Int J Hypertens. 2011 Jan 20;2011:642416. doi: 10.4061/2011/642416.

Resistant hypertension (RH) is a powerful risk factor for cardiovascular morbidity and mortality. Among the characteristics of patients with RH, obesity, obstructive sleep apnea, and aldosterone excess are covering a great area of the mosaic of RH phenotype. Increased...

Cite
Tsioufis C, Kordalis A, Flessas D, et al. Pathophysiology of resistant hypertension: the role of sympathetic nervous system. Int J Hypertens. 2011;2011:642416doi: 10.4061/2011/642416.
Tsioufis, C., Kordalis, A., Flessas, D., Anastasopoulos, I., Tsiachris, D., Papademetriou, V., & Stefanadis, C. (2011). Pathophysiology of resistant hypertension: the role of sympathetic nervous system. International journal of hypertension, 2011642416. https://doi.org/10.4061/2011/642416
Tsioufis, Costas, et al. "Pathophysiology of resistant hypertension: the role of sympathetic nervous system." International journal of hypertension vol. 2011 (2011): 642416. doi: https://doi.org/10.4061/2011/642416
Tsioufis C, Kordalis A, Flessas D, Anastasopoulos I, Tsiachris D, Papademetriou V, Stefanadis C. Pathophysiology of resistant hypertension: the role of sympathetic nervous system. Int J Hypertens. 2011 Jan 20;2011:642416. doi: 10.4061/2011/642416. PMID: 21331155; PMCID: PMC3034926.
Copy Download .nbib Format: NLM
Slowly degradable porous silk microfabricated scaffolds for vascularized tissue formation.

Advanced functional materials

Wray LS, Tsioris K, Gi ES, Omenetto FG, Kaplan DL.
PMID: 24058328
Adv Funct Mater. 2013 Jul 19;23(27):3404-3412. doi: 10.1002/adfm.201202926.

There is critical clinical demand for tissue-engineered (TE), three-dimensional (3D) constructs for tissue repair and organ replacements. Current efforts toward this goal are prone to necrosis at the core of larger constructs because of limited oxygen and nutrient diffusion....

Cite
Wray LS, Tsioris K, Gi ES, et al. Slowly degradable porous silk microfabricated scaffolds for vascularized tissue formation. Adv Funct Mater. 2013;23(27):3404-3412doi: 10.1002/adfm.201202926.
Wray, L. S., Tsioris, K., Gi, E. S., Omenetto, F. G., & Kaplan, D. L. (2013). Slowly degradable porous silk microfabricated scaffolds for vascularized tissue formation. Advanced functional materials, 23(27), 3404-3412. https://doi.org/10.1002/adfm.201202926
Wray, Lindsay S, et al. "Slowly degradable porous silk microfabricated scaffolds for vascularized tissue formation." Advanced functional materials vol. 23,27 (2013): 3404-3412. doi: https://doi.org/10.1002/adfm.201202926
Wray LS, Tsioris K, Gi ES, Omenetto FG, Kaplan DL. Slowly degradable porous silk microfabricated scaffolds for vascularized tissue formation. Adv Funct Mater. 2013 Jul 19;23(27):3404-3412. doi: 10.1002/adfm.201202926. PMID: 24058328; PMCID: PMC3775390.
Copy Download .nbib Format: NLM
Impact of major earthquakes on the incidence of acute coronary syndromes - A systematic review of the literature.

Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese

Bazoukis G, Tse G, Naka KK, Kalfakakou V, Vlachos K, Saplaouras A, Letsas KP, Korantzopoulos P, Thomopoulos C, Michelongona P, Bazoukis X, González-Salvado V, Liu T, Michalis LK, Baranchuk A, Itoh T, Efremidis M, Tsioufis C, Stavrakis S.
PMID: 29807192
Hellenic J Cardiol. 2018 Sep - Oct;59(5):262-267. doi: 10.1016/j.hjc.2018.05.005. Epub 2018 May 25.

Natural disasters such as tsunami, hurricanes, and earthquakes may have a negative impact on cardiac health. The aim of our systematic review is to evaluate the impact of earthquakes on the incidence of acute coronary syndromes and cardiac mortality...

Cite
Bazoukis G, Tse G, Naka KK, et al. Impact of major earthquakes on the incidence of acute coronary syndromes - A systematic review of the literature. Hellenic J Cardiol. 2018;59(5):262-267doi: 10.1016/j.hjc.2018.05.005.
Bazoukis, G., Tse, G., Naka, K. K., Kalfakakou, V., Vlachos, K., Saplaouras, A., Letsas, K. P., Korantzopoulos, P., Thomopoulos, C., Michelongona, P., Bazoukis, X., González-Salvado, V., Liu, T., Michalis, L. K., Baranchuk, A., Itoh, T., Efremidis, M., Tsioufis, C., & Stavrakis, S. (2018). Impact of major earthquakes on the incidence of acute coronary syndromes - A systematic review of the literature. Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese, 59(5), 262-267. https://doi.org/10.1016/j.hjc.2018.05.005
Bazoukis, George, et al. "Impact of major earthquakes on the incidence of acute coronary syndromes - A systematic review of the literature." Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese vol. 59,5 (2018): 262-267. doi: https://doi.org/10.1016/j.hjc.2018.05.005
Bazoukis G, Tse G, Naka KK, Kalfakakou V, Vlachos K, Saplaouras A, Letsas KP, Korantzopoulos P, Thomopoulos C, Michelongona P, Bazoukis X, González-Salvado V, Liu T, Michalis LK, Baranchuk A, Itoh T, Efremidis M, Tsioufis C, Stavrakis S. Impact of major earthquakes on the incidence of acute coronary syndromes - A systematic review of the literature. Hellenic J Cardiol. 2018 Sep - Oct;59(5):262-267. doi: 10.1016/j.hjc.2018.05.005. Epub 2018 May 25. PMID: 29807192.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 211 entries